Lab
Sentara Reference Lab Solutions, LLC
Sentara Reference Lab Solutions, LLC was paid $4.74M by Medicaid between Oct 2021 and Nov 2024, across 314 billing codes. Its largest line is U0004, 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r — 5.7% of everything it billed.
33Billing provider infoSENTARA REFERENCE LAB SOLUTIONS, LLC
NORFOLK, VA 23507
NORFOLK, VA 23507
33aNPI1811524572assigned 03/24/2020
33bProvider typeClinical Medical Laboratory
28Total paid$4.74M
24GClaims1,946,791
24DCodes billed314
24AFirst – last monthOct 2021 – Nov 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Virginia
Rank by total paid#10 of 78
Median peer was paid$37K
This provider vs. median129×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official HANCOCK, MELINDA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 136,652 | $394K | |
| 2022 | 584,155 | $2.17M | |
| 2023 | 644,635 | $1.45M | |
| 2024incomplete | 581,349 | $727K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 5.7% | 7,044 | 6,588 | $271K |
| 80061 | Lipid panel | 5.3% | 109,094 | 104,276 | $251K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 5.0% | 54,014 | 51,218 | $238K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 4.8% | 78,419 | 74,081 | $230K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 4.8% | 78,381 | 74,047 | $229K |
| 80050 | General health panel | 4.8% | 47,496 | 46,002 | $226K |
| 80053 | Comprehensive metabolic panel | 4.7% | 115,096 | 105,380 | $221K |
| 83036 | Hemoglobin; glycosylated (A1C) | 3.1% | 96,954 | 92,447 | $149K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 2.8% | 65,548 | 62,181 | $132K |
| 84443 | Thyroid stimulating hormone (TSH) | 2.7% | 51,584 | 48,436 | $130K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.6% | 87,601 | 80,095 | $124K |
| G0475 | Hiv antigen/antibody, combination assay, screening | 2.0% | 44,834 | 42,758 | $97K |
302 more codes
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | 2.0% | 1,875 | $93K |
| 87481 | 1.9% | 22,571 | $90K | |
| 87536 | 1.9% | 6,621 | $90K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 1.7% | 22,917 | $79K |
| 86803 | 1.7% | 36,349 | $78K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.6% | 11,004 | $77K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 1.5% | 20,788 | $70K |
| 82607 | 1.4% | 26,107 | $67K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.3% | 35,587 | $62K |
| 86780 | 1.2% | 37,784 | $56K | |
| 86235 | 1.2% | 2,961 | $55K | |
| 84439 | 1.1% | 33,298 | $52K | |
| 81420 | Fetal chromosomal aneuploidy genomic sequence analysis panel | <1% | 545 | $46K |
| 85027 | <1% | 31,725 | $45K | |
| 83970 | <1% | 5,708 | $44K | |
| 82728 | <1% | 26,215 | $44K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 48,222 | $40K |
| 88185 | <1% | 829 | $38K | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 9,727 | $38K |
| G0123 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision | <1% | 13,247 | $36K |
| 86003 | <1% | 2,430 | $35K | |
| 82746 | <1% | 14,228 | $34K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 6,019 | $33K |
| 83550 | <1% | 26,712 | $29K | |
| 86361 | <1% | 5,608 | $28K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 2,191 | $28K |
| 87522 | Neg quan hep c or qual rna | <1% | 3,317 | $25K |
| 82043 | <1% | 24,531 | $25K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 94,179 | $23K |
| 83540 | <1% | 28,768 | $23K | |
| 83880 | <1% | 2,782 | $22K | |
| 84403 | <1% | 5,789 | $22K | |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | <1% | 17,858 | $21K |
| 87340 | <1% | 22,327 | $21K | |
| 0225U | <1% | 129 | $21K | |
| 87077 | <1% | 17,593 | $19K | |
| 84481 | <1% | 6,580 | $17K | |
| 83735 | <1% | 12,248 | $16K | |
| 80076 | <1% | 11,546 | $16K | |
| 80055 | <1% | 4,250 | $16K | |
| 87186 | <1% | 12,200 | $14K | |
| 81329 | <1% | 980 | $14K | |
| 80074 | <1% | 4,650 | $14K | |
| 86480 | <1% | 3,024 | $14K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 1,418 | $14K |
| 86038 | <1% | 5,711 | $13K | |
| 86140 | <1% | 11,026 | $13K | |
| 81001 | <1% | 22,735 | $12K | |
| 84402 | <1% | 3,679 | $12K | |
| 84146 | <1% | 4,323 | $12K | |
| 82784 | <1% | 4,335 | $12K | |
| 87081 | <1% | 8,120 | $11K | |
| 83001 | <1% | 4,635 | $11K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 3,370 | $11K |
| 88341 | <1% | 362 | $10K | |
| 88342 | <1% | 1,184 | $10K | |
| 86317 | <1% | 1,930 | $10K | |
| 86225 | <1% | 3,323 | $10K | |
| 82670 | <1% | 2,974 | $10K | |
| 86160 | <1% | 2,149 | $9K | |
| 87150 | <1% | 6,236 | $8K | |
| 86706 | <1% | 5,835 | $8K | |
| 83020 | <1% | 5,694 | $8K | |
| 83002 | <1% | 3,585 | $8K | |
| 87902 | <1% | 355 | $8K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 173 | $8K |
| 82785 | <1% | 2,200 | $8K | |
| 81243 | <1% | 944 | $8K | |
| 86696 | <1% | 3,275 | $8K | |
| 85652 | <1% | 12,337 | $7K | |
| 80069 | <1% | 4,643 | $7K | |
| 86376 | <1% | 2,534 | $7K | |
| 83721 | <1% | 3,339 | $7K | |
| 86787 | <1% | 4,003 | $7K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 725 | $7K |
| 82105 | <1% | 4,909 | $7K | |
| 86334 | <1% | 2,172 | $7K | |
| 82533 | <1% | 2,537 | $7K | |
| 85610 | <1% | 6,584 | $7K | |
| 87529 | <1% | 811 | $7K | |
| 82570 | <1% | 6,676 | $6K | |
| 84153 | <1% | 2,424 | $6K | |
| 87563 | <1% | 3,393 | $6K | |
| 86200 | <1% | 2,288 | $6K | |
| 87070 | <1% | 4,935 | $6K | |
| 84702 | <1% | 8,874 | $6K | |
| 86431 | <1% | 4,736 | $6K | |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | <1% | 1,705 | $6K |
| 83013 | <1% | 637 | $6K | |
| 86704 | <1% | 2,502 | $6K | |
| 84480 | <1% | 2,360 | $6K | |
| 84550 | <1% | 7,298 | $5K | |
| 84425 | <1% | 2,799 | $5K | |
| 86364 | <1% | 1,712 | $5K | |
| 86618 | <1% | 1,030 | $5K | |
| 83520 | <1% | 2,055 | $5K | |
| 86258 | <1% | 1,276 | $5K | |
| 86147 | <1% | 778 | $5K | |
| 88304 | <1% | 842 | $5K | |
| 88184 | <1% | 804 | $5K | |
| 84445 | <1% | 898 | $5K | |
| 87530 | <1% | 638 | $5K | |
| 86695 | <1% | 2,851 | $5K | |
| 83921 | <1% | 1,290 | $5K | |
| 83690 | <1% | 3,181 | $5K | |
| 86800 | <1% | 1,610 | $5K | |
| 86705 | <1% | 2,906 | $5K | |
| 82024 | <1% | 1,457 | $5K | |
| 80197 | <1% | 1,444 | $4K | |
| 80164 | <1% | 1,230 | $4K | |
| 83615 | <1% | 6,102 | $4K | |
| 82627 | <1% | 1,806 | $4K | |
| 84681 | <1% | 1,024 | $4K | |
| 83655 | <1% | 1,679 | $4K | |
| 82550 | <1% | 2,964 | $4K | |
| 82565 | <1% | 4,593 | $4K | |
| 84100 | <1% | 4,741 | $4K | |
| 82378 | <1% | 1,637 | $4K | |
| 86832 | <1% | 98 | $4K | |
| 87493 | <1% | 428 | $4K | |
| 83516 | <1% | 775 | $3K | |
| 84165 | <1% | 1,800 | $3K | |
| 84156 | <1% | 5,759 | $3K | |
| 86833 | <1% | 98 | $3K | |
| 86341 | <1% | 695 | $3K | |
| 86708 | <1% | 1,295 | $3K | |
| 82652 | <1% | 562 | $3K | |
| 82950 | <1% | 6,927 | $3K | |
| 86039 | <1% | 1,442 | $3K | |
| 86762 | <1% | 3,832 | $3K | |
| 84460 | <1% | 3,307 | $3K | |
| 80177 | <1% | 1,056 | $3K | |
| 87205 | <1% | 3,564 | $3K | |
| 85046 | <1% | 2,438 | $3K | |
| 84450 | <1% | 3,181 | $3K | |
| 83521 | <1% | 573 | $3K | |
| 86360 | <1% | 731 | $3K | |
| 82951 | <1% | 1,518 | $3K | |
| 83498 | <1% | 849 | $2K | |
| 87517 | <1% | 314 | $2K | |
| 83525 | <1% | 1,580 | $2K | |
| 86850 | <1% | 5,200 | $2K | |
| 86677 | <1% | 759 | $2K | |
| 82248 | <1% | 1,599 | $2K | |
| 84436 | <1% | 2,661 | $2K | |
| 87209 | <1% | 687 | $2K | |
| 87899 | <1% | 727 | $2K | |
| 86593 | <1% | 3,411 | $2K | |
| 87255 | <1% | 1,025 | $2K | |
| 84154 | <1% | 598 | $2K | |
| 87901 | <1% | 150 | $2K | |
| 87427 | <1% | 735 | $2K | |
| 86146 | <1% | 502 | $2K | |
| 83993 | <1% | 508 | $2K | |
| 86769 | <1% | 232 | $2K | |
| 82985 | <1% | 667 | $2K | |
| 86008 | <1% | 327 | $2K | |
| 84144 | <1% | 1,049 | $2K | |
| 86037 | <1% | 252 | $2K | |
| 82977 | <1% | 1,646 | $2K | |
| 86828 | <1% | 255 | $2K | |
| 81003 | <1% | 4,918 | $2K | |
| 84207 | <1% | 276 | $2K | |
| 83010 | <1% | 1,099 | $2K | |
| 86665 | <1% | 353 | $2K | |
| 87625 | <1% | 457 | $2K | |
| 82247 | <1% | 776 | $2K | |
| 83718 | <1% | 1,015 | $2K | |
| 85730 | <1% | 2,250 | $2K | |
| 80178 | <1% | 706 | $1K | |
| 86300 | <1% | 1,590 | $1K | |
| 82465 | <1% | 1,746 | $1K | |
| 82164 | <1% | 505 | $1K | |
| 86900 | <1% | 5,047 | $1K | |
| 86901 | <1% | 5,045 | $1K | |
| 84478 | <1% | 1,114 | $1K | |
| 82088 | <1% | 299 | $1K | |
| 82330 | <1% | 801 | $1K | |
| 82172 | <1% | 808 | $1K | |
| 85379 | <1% | 1,204 | $1K | |
| 84520 | <1% | 2,036 | $1K | |
| 84703 | <1% | 836 | $1K | |
| 80373 | <1% | 852 | $1K | |
| 87900 | <1% | 150 | $1K | |
| 85613 | <1% | 752 | $1K | |
| 87449 | <1% | 302 | $1K | |
| 82677 | <1% | 557 | $1K | |
| 82040 | <1% | 1,328 | $1K | |
| 87497 | <1% | 118 | $1K | |
| 87634 | <1% | 20 | $1K | |
| 86381 | <1% | 320 | $988.34 | |
| 82672 | <1% | 335 | $976.93 | |
| 81025 | <1% | 656 | $971.39 | |
| 87045 | <1% | 727 | $966.07 | |
| 82525 | <1% | 392 | $949.37 | |
| 81374 | <1% | 132 | $918.08 | |
| 84466 | <1% | 473 | $907.38 | |
| 87177 | <1% | 670 | $875.89 | |
| 86735 | <1% | 617 | $875.19 | |
| 84479 | <1% | 1,014 | $864.73 | |
| 86336 | <1% | 611 | $825.17 | |
| 86709 | <1% | 864 | $803.35 | |
| 82103 | <1% | 258 | $747.69 | |
| 86707 | <1% | 272 | $733.79 | |
| 87102 | <1% | 401 | $727.04 | |
| 84630 | <1% | 365 | $725.40 | |
| 87338 | <1% | 615 | $713.58 | |
| 82952 | <1% | 1,272 | $687.31 | |
| 80156 | <1% | 132 | $683.36 | |
| 84244 | <1% | 262 | $683.28 | |
| 86765 | <1% | 613 | $676.17 | |
| 86335 | <1% | 128 | $649.68 | |
| 86162 | <1% | 130 | $648.01 | |
| 82150 | <1% | 462 | $645.00 | |
| 85018 | <1% | 2,246 | $636.91 | |
| 86015 | <1% | 289 | $629.00 | |
| 84132 | <1% | 708 | $619.86 | |
| 82947 | <1% | 1,066 | $611.99 | |
| 87350 | <1% | 373 | $577.98 | |
| 86592 | <1% | 601 | $550.05 | |
| 82390 | <1% | 288 | $549.90 | |
| 87046 | <1% | 613 | $541.61 | |
| 81241 | <1% | 40 | $534.08 | |
| 84305 | <1% | 166 | $523.24 | |
| 86355 | <1% | 162 | $518.16 | |
| 84432 | <1% | 140 | $500.69 | |
| 85014 | <1% | 1,881 | $475.04 | |
| 83883 | <1% | 218 | $461.80 | |
| 80175 | <1% | 148 | $446.14 | |
| 86256 | <1% | 84 | $422.09 | |
| 86304 | <1% | 265 | $402.71 | |
| 88112 | <1% | 164 | $383.00 | |
| 80349 | <1% | 310 | $374.92 | |
| 87430 | <1% | 241 | $365.55 | |
| 82668 | <1% | 344 | $361.08 | |
| 86617 | <1% | 63 | $360.33 | |
| 85660 | <1% | 879 | $353.37 | |
| 86664 | <1% | 111 | $352.65 | |
| 87210 | <1% | 402 | $332.77 | |
| 82107 | <1% | 42 | $324.00 | |
| 86141 | <1% | 341 | $323.02 | |
| 80202 | <1% | 130 | $321.21 | |
| 82140 | <1% | 52 | $310.71 | |
| 86036 | <1% | 309 | $302.55 | |
| 82310 | <1% | 216 | $270.99 | |
| 85306 | <1% | 80 | $268.93 | |
| 87799 | <1% | 31 | $252.24 | |
| 87109 | <1% | 280 | $252.21 | |
| 83835 | <1% | 79 | $243.70 | |
| 85048 | <1% | 226 | $219.25 | |
| 84270 | <1% | 97 | $204.58 | |
| 80324 | <1% | 142 | $203.23 | |
| 80183 | <1% | 44 | $193.09 | |
| 82239 | <1% | 72 | $180.62 | |
| 86880 | <1% | 217 | $170.31 | |
| 86301 | <1% | 187 | $159.20 | |
| 84075 | <1% | 158 | $152.73 | |
| 86413 | <1% | 13 | $151.12 | |
| 82397 | <1% | 74 | $142.48 | |
| 87329 | <1% | 45 | $141.36 | |
| 87185 | <1% | 264 | $122.44 | |
| 83695 | <1% | 252 | $109.08 | |
| 82656 | <1% | 31 | $95.92 | |
| 86308 | <1% | 49 | $95.47 | |
| 80299 | <1% | 25 | $89.56 | |
| 84484 | <1% | 45 | $89.29 | |
| 86663 | <1% | 27 | $88.85 | |
| 83519 | <1% | 14 | $86.36 | |
| 87075 | <1% | 61 | $85.18 | |
| 85049 | <1% | 183 | $66.93 | |
| 87140 | <1% | 107 | $64.32 | |
| 85302 | <1% | 27 | $63.66 | |
| 83014 | <1% | 163 | $57.26 | |
| 86644 | <1% | 30 | $55.20 | |
| 82747 | <1% | 59 | $54.90 | |
| 82626 | <1% | 12 | $50.61 | |
| 82653 | <1% | 27 | $49.38 | |
| 86645 | <1% | 25 | $46.00 | |
| 85300 | <1% | 28 | $45.88 | |
| 86870 | <1% | 13 | $42.60 | |
| 82085 | <1% | 13 | $41.75 | |
| 85303 | <1% | 17 | $41.52 | |
| 82575 | <1% | 43 | $40.57 | |
| 85246 | <1% | 45 | $38.05 | |
| 85384 | <1% | 59 | $28.78 | |
| 87076 | <1% | 29 | $28.20 | |
| 87206 | <1% | 12 | $26.95 | |
| 87535 | <1% | 15 | $22.81 | |
| 89055 | <1% | 25 | $16.63 | |
| 82232 | <1% | 45 | $16.18 | |
| 36416 | <1% | 153 | $15.18 | |
| 81511 | <1% | 76 | $13.50 | |
| 85240 | <1% | 15 | $11.64 | |
| 83527 | <1% | 13 | $8.42 | |
| P9603 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled | <1% | 19 | $5.47 |
| 80362 | 0% | 12 | $0.00 | |
| 85245 | 0% | 37 | $0.00 | |
| 80348 | 0% | 13 | $0.00 | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 0% | 12 | $0.00 |
| 84080 | 0% | 15 | $0.00 | |
| 86005 | 0% | 13 | $0.00 | |
| 81596 | 0% | 114 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHANCOCK, MELINDA (EVP, CHIEF FINANCIAL OFFICER)
| Provider | Location | Paid |
|---|---|---|
| Sentara Hospitals | Norfolk, VA | $88.20M |
| Sentara Hospitals | Norfolk, VA | $79.69M |
| Sentara Hospitals | Hampton, VA | $78.52M |
| Potomac Hospital Corporation of Prince William | Woodbridge, VA | $59.17M |
| Sentara Hospitals | Suffolk, VA | $57.85M |
| Sentara RMH Medical Center | Harrisonburg, VA | $52.95M |
| Sentara Hospitals | Virginia Beach, VA | $52.40M |
| Sentara Princess Anne Hospital | Virginia Beach, VA | $37.50M |
| Martha Jefferson Hospital | Charlottesville, VA | $26.95M |
| Halifax Regional Hospital, INC. | South Boston, VA | $23.28M |
| Sentara Hospitals | Williamsburg, VA | $21.89M |
| Sentara Albemarle Regional Medical Center | Elizabeth City, NC | $13.82M |
| Halifax Regional Hospital, INC | South Boston, VA | $1.61M |
| Halifax Regional Hospital, INC | Nathalie, VA | $348K |
| Halifax Regional Hospital, INC | South Boston, VA | $336K |
| Halifax Regional Hospital, INC | Chase City, VA | $298K |
| Halifax Regional Hospital, INC | Clarksville, VA | $265K |
| Sentara Hospitals | Norfolk, VA | $171K |
| Halifax Regional Hospital, INC | South Boston, VA | $170K |
| Sentara Hospitals | Norfolk, VA | $128K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.